3Sancho JJ,di Costanzo J,Nubiola P,et al.Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistulas[J].Br J Surg,1995,82(5):638-641.
4Martineau P,Shwed JA,Denis R.Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?[J].Am J Surg,1996,172(4):386-395.
5Daly JM.The evolution of surgical nutrition:nutrition and anabolic interventions[J].Ann Surg,1999,229(1):19-20.
6Alvarez C,McFadden DW,Reber HA.Complicated enterocutaneous fistulas:failure of octreotide to improve healing[J].World J Surg,2000,24(5):533-537.
7Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,101:1028.
8Koch T.Origin and mediators involved in sepsis and the systemic inflammatory response syndrome[J].Kidney Int,1998,53(Suppl 64):S66.
9Heidekmann SM, Ofenstein JP, Sarnaik AP.Efficacy of conti nuous arteriovenous hemofiltration in endotoxic shock[J].Circ Shock,1994,44:183.
10Rogiers P,Zhang H,Smail N,et al.High-volume hemofiltration improves hemodnamics in experimental endotoxic shock[J].Inten Care Med,1996,22:S396.
